agilon health (NYSE:AGL – Free Report) had its price target trimmed by Barclays from $5.00 to $2.00 in a research note released on Monday morning,Benzinga reports. The firm currently has an underweight rating on the stock.
A number of other brokerages also recently weighed in on AGL. William Blair downgraded agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Citigroup reiterated a “sell” rating and set a $2.50 price target (down from $7.00) on shares of agilon health in a report on Tuesday, October 29th. JMP Securities downgraded agilon health from an “outperform” rating to a “market perform” rating in a report on Monday. Evercore ISI decreased their price target on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a report on Tuesday, October 8th. Finally, Benchmark reissued a “buy” rating and set a $9.00 price objective on shares of agilon health in a research report on Thursday, August 8th. Three analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, agilon health currently has a consensus rating of “Hold” and an average target price of $6.38.
View Our Latest Analysis on AGL
agilon health Stock Performance
agilon health (NYSE:AGL – Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The company had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter in the previous year, the company earned ($0.06) earnings per share. Sell-side analysts expect that agilon health will post -0.35 EPS for the current year.
Insider Transactions at agilon health
In related news, CEO Steven Sell purchased 20,000 shares of the firm’s stock in a transaction dated Thursday, September 12th. The stock was bought at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the purchase, the chief executive officer now directly owns 67,590 shares in the company, valued at approximately $227,102.40. This trade represents a 42.03 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 3.20% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the business. J.Safra Asset Management Corp grew its stake in agilon health by 626.1% in the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after buying an additional 3,625 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in agilon health in the 3rd quarter valued at $28,000. CWM LLC boosted its holdings in agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after purchasing an additional 7,288 shares during the period. Nisa Investment Advisors LLC bought a new position in agilon health in the 2nd quarter valued at $60,000. Finally, Bleakley Financial Group LLC bought a new position in agilon health in the 1st quarter valued at $65,000.
About agilon health
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
See Also
- Five stocks we like better than agilon health
- The Risks of Owning Bonds
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- How to Plot Fibonacci Price Inflection Levels
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.